ACLARIS THERAPEUTICS, INC.

Company

Aclaris Therapeutics, Inc.

Filed

June 26, 2020

Accession Number

0000902664-20-002531

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →